BriaCell Therapeutics Corp Warrant
Quarterly Financials
| Values in thousands | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,161 | -7,143 | -5,126 | -7,143 |
EBIT | -6,187 | -7,169 | -5,152 | -7,169 |
Net Income | -6,126 | -6,291 | -5,802 | -1,214 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,162 | -5,920 | -6,955 | -4,492 |
Cash | 12,460 | 5,013 | 5,792 | 862 |
Basic Shares | 3,735 | 2,699 | 26,641 | 1,218 |
Annual Financials
| Values in thousands | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -33,246 | -23,257 | -26,823 | -13,722 |
EBIT | -33,329 | -23,272 | -26,838 | -13,737 |
Net Income | -4,791 | -20,302 | -26,839 | -13,816 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -24,582 | -23,744 | -12,484 | -7,750 |
Cash | 862 | 21,251 | 41,041 | 57,268 |
Basic Shares | 1,218 | 1,065 | 1,034 | 1,017 |
